United States · FDA National Drug Code directory
levothyroxine sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-1465_5dd258ee-53fd-4e60-b3c9-b3cfacd622bf
- Product NDC
- 71335-1465
- Form
- TABLET
- Composition / generic term
- levothyroxine sodium
- Labeler
- Bryant Ranch Prepack
- Marketing category
- NDA
- Marketing start / end (source format)
- 20190507
- Source listing expiry
- 20261231
Source-listed ingredients
- LEVOTHYROXINE SODIUM — 112 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (71335-1465-1) · 71335-1465-1
- 90 TABLET in 1 BOTTLE (71335-1465-2) · 71335-1465-2
- 60 TABLET in 1 BOTTLE (71335-1465-3) · 71335-1465-3
- 18 TABLET in 1 BOTTLE (71335-1465-4) · 71335-1465-4
- 100 TABLET in 1 BOTTLE (71335-1465-5) · 71335-1465-5
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →